These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

924 related items for PubMed ID: 8919160

  • 1. Maternal serum markers for Down's syndrome pregnancies.
    Chew S, Anandakumar C, Ratnam SS.
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [Abstract] [Full Text] [Related]

  • 2. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
    Chang TC, Cheng HH.
    Med J Malaysia; 1994 Dec; 49(4):351-4. PubMed ID: 7545778
    [Abstract] [Full Text] [Related]

  • 3. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Dec; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 4. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S, Chandeying V.
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [Abstract] [Full Text] [Related]

  • 5. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA.
    N Engl J Med; 1994 Apr 21; 330(16):1114-8. PubMed ID: 7510852
    [Abstract] [Full Text] [Related]

  • 6. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R, Reynolds TM, John R, Spencer K, Bartels I, Coombes E, Trevor S.
    Prenat Diagn; 1996 Jan 21; 16(1):79-82. PubMed ID: 8821858
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY, Fu P, Zhang ZH, Wang F, Han MY, Ren HY, Zhao W, Zhang K, Li S, Jiang N.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun 21; 28(3):332-5. PubMed ID: 21644235
    [Abstract] [Full Text] [Related]

  • 8. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D, Bradbury I, Malone F, D'Alton M, Summers A, Huang T, Ball S, Baker A, Nix B, Aitken D, Crossley J, Cuckle H, Spencer K.
    Health Technol Assess; 2010 Jul 21; 14(33):1-80. PubMed ID: 20624355
    [Abstract] [Full Text] [Related]

  • 9. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG.
    Prenat Diagn; 1996 Feb 21; 16(2):143-53. PubMed ID: 8650125
    [Abstract] [Full Text] [Related]

  • 10. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
    Lam YH, Ghosh A, Tang MH, Tang LC, Lee CP, Sin SY, Ho PK.
    Prenat Diagn; 1998 Jun 21; 18(6):585-89. PubMed ID: 9664604
    [Abstract] [Full Text] [Related]

  • 11. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P, Bischof P, Marguerat P, Mermillod B.
    Hum Reprod; 1998 Jan 21; 13(1):220-3. PubMed ID: 9512261
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J, Skrablin S, Durić K, Suchanek E, Muzinić D, Kalafatić D, Kuvacić I, Zlopasa G, Plavec A.
    Lijec Vjesn; 2003 Jan 21; 125(3-4):55-60. PubMed ID: 12899094
    [Abstract] [Full Text] [Related]

  • 15. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G, Goldman B, Ries L, Chaki R, Cuckle H.
    Prenat Diagn; 1996 Apr 21; 16(4):319-22. PubMed ID: 8734805
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM.
    J Med Screen; 1998 Apr 21; 5(3):115-9. PubMed ID: 9795869
    [Abstract] [Full Text] [Related]

  • 18. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ, Watt HC.
    Prenat Diagn; 1996 Aug 21; 16(8):699-703. PubMed ID: 8878278
    [Abstract] [Full Text] [Related]

  • 19. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
    Shackley P, McGuire A, Boyd PA, Dennis J, Fitchett M, Kay J, Roche M, Wood P.
    J Public Health Med; 1993 Jun 21; 15(2):175-84. PubMed ID: 7688977
    [Abstract] [Full Text] [Related]

  • 20. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
    Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM.
    Prenat Diagn; 1996 Dec 21; 16(12):1095-100. PubMed ID: 8994244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.